QIAGEN NV has published the transcript of its third quarter 2025 results call, held to discuss the company's latest financial and operational performance. The event was attended by key members of management, including the Chief Executive Officer, Chief Financial Officer, Vice President of Corporate Communications, and newly appointed Vice President and Head of Investor Relations. During the call, management highlighted another strong quarter for QIAGEN, with results exceeding the company's outlook. The CEO emphasized the company's ongoing commitment to strengthening its portfolio and delivering increased returns to shareholders, stating, "QIAGEN delivered another strong quarter - once again exceeding our outlook. And just as important, we took decisive action to strengthen our portfolio and increase returns to shareholders, all aligned with our 2028 ambitions." Management also discussed the continued success of its core business pillars, spanning from basic research to clinical diagnostics, and announced upcoming product launches designed to drive future growth. Additionally, the call mentioned the forthcoming Deep Dive on Sample technologies scheduled for November 21, inviting stakeholders to participate in the session. The full transcript can be accessed through the link below.